Clinical Chemistry Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Clinical Chemistry 50: 1250-1253, 2004; 10.1373/clinchem.2004.032995
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via ISI Web of Science (7)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Faucher, S.
Right arrow Articles by Mandy, F. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Faucher, S.
Right arrow Articles by Mandy, F. F.
Related Collections
Right arrow Clinical Immunology
Right arrow Proteomics and Protein Markers
(Clinical Chemistry. 2004;50:1250-1253.)
© 2004 American Association for Clinical Chemistry, Inc.


Technical Briefs

Protein Bead Array for the Detection of HIV-1 Antibodies from Fresh Plasma and Dried-Blood-Spot Specimens

Sylvie Faucher1,a, Alexandre Martel1, Alice Sherring1, Tao Ding1, Laurie Malloch2, John E. Kim2, Michèle Bergeron1, Paul Sandstrom3 and Francis F. Mandy1

1 National HIV Immunology Laboratory, National HIV and Retrovirology Laboratories, Centre for Infectious Disease Prevention and Control, Health Canada, Ottawa, ON, Canada;2 National Laboratory for HIV Reference Services, National HIV and Retrovirology Laboratories, Centre for Infectious Disease Prevention and Control, Health Canada, Ottawa, ON, Canada;3 National HIV and Retrovirology Laboratories, Centre for Infectious Disease Prevention and Control, Health Canada, Ottawa, ON, Canada

aaddress correspondence to this author at: National HIV Immunology Laboratory, National HIV and Retrovirology Laboratories, Centre for Infectious Disease Prevention and Control, Bldg. 6, P.L. 0603B1, Tunney’s Pasture, Ottawa, Ontario, Canada K1A 0L2; fax 613-946-3237, e-mail sylvie_faucher@hc-sc.gc.ca

The first 300 words of the full text of this article appear below.

Simultaneous multianalyte immunoassays offer advantages, including reduction of technical operations, execution time, and overall costs. The suspension array technology (SAT), which uses microfluorospheres with flow cytometry, is a multianalyte immunoassay that requires small specimen volumes, such as those obtained by less-invasive blood sampling approaches such as heel or finger sticks, as well as those obtained in pediatric specimens. The dried-blood-spot (DBS) technology has become an important screening tool for clinical and epidemiologic testing (1)(2)(3). It is particularly convenient in rural, resource-limited settings where trained personnel and adequate facilities for blood collection, processing, transport, and storage may not be available. This approach, however, provides limited specimen volume (~5–6 µL of serum/6-mm punch) (2). Fortunately, SAT is well suited to support such a format (4)(5).

The range of applications for SAT includes antibody, oligonucleotide, peptide, and protein bead arrays (PBAs) (4)(6)(7)(8)(9)(10)(11)(12)(13)(14)(15)(16)(17). PBAs have been used for the simultaneous detection of serum antibodies to infectious agents for systemic candidiasis (18), herpes viruses (19), measles, mumps (20), and HIV (21)(22). The successful detection of HIV-1 serum antibodies by a four-protein bead array was first reported by Scillian et al. (21), who used beads of various sizes and proteins noncovalently coupled to beads. Reagents are now available that permit covalent coupling of proteins to beads and simultaneous analysis of up to 100 color-coded bead sets in a high-throughput, 96-well plate format. In addition, a new generation of flow cytometers compatible with SAT has recently been introduced, e.g., the Luminex-100 System (Luminex Corp.) and the . . . [Full Text of this Article]







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2004 by the American Association for Clinical Chemistry.